Leder P - Search Results

1

P53 levels determine outcome during beta-catenin tumor initiation and metastasis in the mammary gland and male germ cells.

Ridgeway AG, McMenamin J, Leder P. Ridgeway AG, et al. Among authors: leder p. Oncogene. 2006 Jun 15;25(25):3518-27. doi: 10.1038/sj.onc.1209391. Epub 2006 Jan 23. Oncogene. 2006. PMID: 16434961

2

A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth.

Martin SS, Ridgeway AG, Pinkas J, Lu Y, Reginato MJ, Koh EY, Michelman M, Daley GQ, Brugge JS, Leder P. Martin SS, et al. Among authors: leder p. Oncogene. 2004 Jun 3;23(26):4641-5. doi: 10.1038/sj.onc.1207595. Oncogene. 2004. PMID: 15064711

3

Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.

Leder A, McMenamin J, Zhou F, Moran JL, Beier DR, Leder P. Leder A, et al. Among authors: leder p. Oncogene. 2008 Apr 10;27(17):2456-65. doi: 10.1038/sj.onc.1210866. Epub 2007 Oct 22. Oncogene. 2008. PMID: 17952114

4

beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.

Michaelson JS, Leder P. Michaelson JS, et al. Among authors: leder p. Oncogene. 2001 Aug 23;20(37):5093-9. doi: 10.1038/sj.onc.1204586. Oncogene. 2001. PMID: 11526497

5

Genomic instability resulting from Blm deficiency compromises development, maintenance, and function of the B cell lineage.

Babbe H, McMenamin J, Hobeika E, Wang J, Rodig SJ, Reth M, Leder P. Babbe H, et al. Among authors: leder p. J Immunol. 2009 Jan 1;182(1):347-60. doi: 10.4049/jimmunol.182.1.347. J Immunol. 2009. PMID: 19109166 Free PMC article.

6

zeta-/- Thalassemic mice are affected by two modifying loci and display unanticipated somatic recombination leading to inherited variation.

Leder A, McMenamin J, Fontaine K, Bishop A, Leder P. Leder A, et al. Among authors: leder p. Hum Mol Genet. 2005 Mar 1;14(5):615-25. doi: 10.1093/hmg/ddi058. Epub 2005 Jan 13. Hum Mol Genet. 2005. PMID: 15649944

7

The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.

Elson A, Deng C, Campos-Torres J, Donehower LA, Leder P. Elson A, et al. Among authors: leder p. Oncogene. 1995 Jul 6;11(1):181-90. Oncogene. 1995. PMID: 7624126

8

Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.

Kitsberg DI, Leder P. Kitsberg DI, et al. Among authors: leder p. Oncogene. 1996 Dec 19;13(12):2507-15. Oncogene. 1996. PMID: 9000125

9

Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.

Lane TF, Leder P. Lane TF, et al. Among authors: leder p. Oncogene. 1997 Oct;15(18):2133-44. doi: 10.1038/sj.onc.1201593. Oncogene. 1997. PMID: 9393971

10

Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.

Brodie SG, Xu X, Li C, Kuo A, Leder P, Deng CX. Brodie SG, et al. Among authors: leder p. Oncogene. 2001 Mar 22;20(12):1445-54. doi: 10.1038/sj.onc.1204222. Oncogene. 2001. PMID: 11313888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters